Lv64
2980 积分 2024-06-17 加入
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update
4天前
已完结
The changing face of axial spondyloarthritis over the last 25 years
6天前
已关闭
A Phase 3 Trial of Brepocitinib in Dermatomyositis
1个月前
已完结
Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis: the ROC-SpA study, a randomised controlled study protocol
1个月前
已关闭
Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial
1个月前
已完结
Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial
1个月前
已完结
Tumor Necrosis Factor-α Inhibitors, Immune-Mediated Inflammatory Diseases, and Bloodstream Infections: Results from a Nationwide Case-Control Study
3个月前
已完结
Tumor Necrosis Factor-α Inhibitors, Immune-Mediated Inflammatory Diseases, and Bloodstream Infections: Results from a Nationwide Case-Control Study
3个月前
已关闭
Effects of concomitant methotrexate and predictors of remission in Janus kinase inhibitor therapy for rheumatoid arthritis
4个月前
已关闭
Effects of concomitant methotrexate and predictors of remission in Janus kinase inhibitor therapy for rheumatoid arthritis
4个月前
已关闭
皖公网安备34019202002308
